Aaron Boster
2PUBLICATIONS
5CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (2)
Sort by Publication Date:
|Dec 09, 2021
Autoimmunity and long-term safety and efficacy of alemtuzumab for multiple sclerosis: Benefit/risk following review of trial and post-marketing data.Alasdair J Coles, Joanne L Jones, Patrick Vermersch
|Jan 08, 2021
Proportion of alemtuzumab-treated patients converting from relapsing-remitting multiple sclerosis to secondary progressive multiple sclerosis over 6 years.Dana Horáková, Aaron Boster, Antonio Bertolotto
Pageof 1
